AGILE THERAPEUTICS INC - 00847L100

Sector: Healthcare · Industry: Pharmaceutical Preparations
Website: No information yet · Social: No information yet

Company profile

Description is not available for this instrument yet.

Quarter snapshot

Latest / Compare
Q1 2022 · Q4 2021
Value (USD)
Total reported value ($000)
$182.2M
QoQ value delta ($000)
+$166.9M (+1091.13%)
Implied price effect (QoQ)
+961.62%
Shares
Total shares
39,087,662
QoQ shares delta
+4,249,791 (+12.2%)
Total shares held by funds (by quarter)

Top holders (Q1 2022)

Top 25 only Full list
Manager Value ($000) Shares % of 13F
PERCEPTIVE ADVISORS LLC 178,447 21,294,485 3.57%
ARMISTICE CAPITAL, LLC 953 4,547,100 0.02%
VANGUARD GROUP INC 812 3,877,347 0.0%
INVESTOR AB 737 3,510,189 0.02%
D. E. Shaw & Co., Inc. 460 2,197,334 0.0%
MILLENNIUM MANAGEMENT LLC 176 841,118 0.0%
GEODE CAPITAL MANAGEMENT, LLC 158 757,888 0.0%
RENAISSANCE TECHNOLOGIES LLC 130 621,200 0.0%
STATE STREET CORP 61 290,345 0.0%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 44 210,812 0.0%
FIRST CITIZENS BANK & TRUST CO 42 200,000 0.0%
NORTHERN TRUST CORP 30 144,816 0.0%
GRIMES & COMPANY, INC. 23 111,819 0.0%
CITADEL ADVISORS LLC 21 102,847 0.0%
ADVISOR GROUP HOLDINGS, INC. 15 72,950 0.0%
UBS Group AG 12 56,034 0.0%
MORGAN STANLEY 10 51,812 0.0%
GROUP ONE TRADING, L.P. 9 41,277 0.0%
Bank of New York Mellon Corp 9 40,667 0.0%
HBK Sorce Advisory LLC 7 35,000 0.0%
CITIGROUP INC 5 23,580 0.0%
LPL Financial LLC 4 20,244 0.0%
Tower Research Capital LLC (TRC) 4 19,670 0.0%
Creative Planning 2 10,200 0.0%
JPMORGAN CHASE & CO 0 110 0.0%